Central Florida Rheumatology Consultants

From Black Box to Revenue Control:

Transforming a Multi-Location Rheumatology Practice

A multi-location rheumatology practice in Central Florida, specializing in complex autoimmune and musculoskeletal care, was losing revenue it couldn’t see. High-value biologic claims were breaking down silently, denials were compounding across treatment cycles, and no one had visibility into where the money was going.

By partnering with EMPClaims, the practice cut its claim denial rate in half — from 40% to 20–25% — and gained full transparency into its revenue lifecycle for the first time.

Get a Demo
Eligibility Agent
Wurklist Real-Time Verification
Online
Extracting plans from EMR... 08:41 AM
Extracted plans for Margaret Rowan: 08:41 AM
Aetna Open Access PPO
AET-W882471603
Primary
Humana Gold Plus HMO
HUM-MA-6039284
Secondary
Checking eligibility for infusion date 03/31/2026 08:41 AM
Auto-login complete — Availity / Aetna 08:41 AM
Eligibility confirmed — Aetna PPO Active 08:41 AM
Auto-login complete — Availity / Humana 08:42 AM
Eligibility confirmed — Humana MA Active 08:42 AM
Prior auth expiring — J1745 (infliximab) auth ends 03/28 08:42 AM
Authorization Gap Detected
Drug Infliximab 300mg (J1745 × 30 units)
Auth # AET-PA-20260114-7841
Auth Expires 03/28/2026
Next Infusion 03/31/2026
Gap 3 days — infusion will be denied without reauth
Pulling specialty drug benefits for Aetna PPO... 08:42 AM

💬Auth for infliximab expires before the next scheduled infusion. Reauthorization is needed to prevent a denial on 03/31. Benefit summary below.

Specialty Drug Benefits — Aetna PPO
Infusion Coinsurance 20% after deductible
Deductible Remaining $412.00 of $2,500
OOP Accumulator $4,188 of $6,500 max
Specialty Tier Medical Benefit — Buy & Bill
Requires your confirmation
Checking for updates in EHR... 08:42 AM

💬I found updates to post to your EMR. Review and click Update.

Patient Updates
Aetna PPO · Group Number
GRP-88410 → GRP-88410-R2
Authorization Updates
J1745 Auth Status
Active → Expiring 03/28 — Reauth Required
Humana MA · OOP Accumulator
$3,200 → $0.00 (reset 01/01/26)
EMR updated — reauth flagged for auth team 08:43 AM
Verification Complete

Every action visible. Every step auditable.

Executive Summary

Executive Summary

A multi-location rheumatology practice in Central Florida, specializing in complex autoimmune and musculoskeletal care, was losing revenue it couldn’t see. High-value biologic claims were breaking down silently, denials were compounding across treatment cycles, and no one had visibility into where the money was going.

By partnering with EMPClaims, the practice cut its claim denial rate in half — from 40% to 20–25% — and gained full transparency into its revenue lifecycle for the first time.

Stat Label
50% Denial Rate Reduction
40% → 20–25% Claims Now Processed Cleanly
The Challenge

The Challenge

Despite strong patient volume, the practice was operating its revenue cycle in the dark. Key pain points included:

Biologic Revenue at Risk

Complex HCPCS drug codes, dosage unit billing, and modifier requirements were generating repeat denials — but without pattern-level visibility, the same errors compounded month over month.

Authorization Gaps

Manual tracking led to expired approvals mid-treatment and services rendered without confirmed authorization.

Denial Patterns in the Dark

With denial rates at 40%, claims were being reworked individually with no root-cause analysis. The practice was fighting the same fires on repeat.

Cash Flow Paralysis

Unresolved claims accumulated in AR with no structured follow-up and no visibility into what was recoverable.

View Full Case Study

14-location AFC network results

The Solution

The Solution: People + Process + AI

EMPClaims deployed a strategic RCM overhaul — not just cleaner billing, but full visibility and control.

Revenue Visibility

Deployed the Wurklist platform to replace fragmented workflows with real-time dashboards — claim status, denial trends, payer behavior, and AR aging visible for the first time.

 

AI-Powered Claim Integrity

Implemented the Billing Rules Engine with rheumatology-specific rules — CPT/ICD cross-checks, HCPCS drug code validation, and modifier logic scrubbing every claim before submission. Errors caught before they become denials.

Authorization Lifecycle Control

Replaced manual tracking with structured workflows — authorizations verified before service, approval limits tracked across treatment cycles, expirations flagged early.

Aggressive AR Recovery

Analyzed denial patterns at the root-cause level to stop repeat denials at the source. Structured follow-up cadence on every outstanding claim. No silent write-offs.
Key Performance Metrics

Key Performance Metrics

Metric Before EMPClaims After EMPClaims The Impact
Claim Denial Rate 40% 20–25% 50% reduction — fewer denials, less rework
Days in AR No structured tracking Active follow-up cadence Every outstanding claim owned and worked
Business Impact

Business Impact

By replacing a black box billing operation with a Revenue Command Center, the practice now operates with.

Full Revenue Visibility

Real-time dashboards that drive action, not backward-looking reports

A Strategic Partner

Weekly touchpoints, proactive risk identification, embedded financial oversight

Clinical Focus Restored

Providers treating patients, EMPClaims protecting the revenue

"Rheumatology revenue is built on consistency and discipline, not just speed. Payers remember patterns - and so do we."

People + Process + AI. No Claim Left Behind.

Ready to see what's hiding in your revenue cycle?

Contact EMPClaims for a comprehensive revenue assessment.
Schedule Your Assessment
Scroll to Top